−0.0008 EUR
−709.00 K EUR
40.56 M EUR
1.35 B
About EUROPEAN MEDICAL SOLUTION
Sector
Industry
CEO
Frank Hazevoets
Website
Headquarters
Liege
Founded
1997
ISIN
BE0974289218
FIGI
BBG00CSTMNP7
European Medical Solutions is a clinical stage biopharmaceutical company, which engages in the research and development of immunotherapy treatments for environmental and food allergies. Its products include gp-ASIT+, which is developed for the treatment of allergic rhinitis due to grass pollen; hdm-ASIT+, for the treatment of house dust mite allergy; and pnt-ASIT+for the treatment of peanut allergy. The company was founded by Thierry Legon in 1997 and is headquartered in Liege, Belgium.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALEMS is 0.0180 EUR — it has decreased by −3.23% in the past 24 hours. Watch EUROPEAN MEDICAL SOLUTION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange EUROPEAN MEDICAL SOLUTION stocks are traded under the ticker ALEMS.
ALEMS stock has fallen by −9.09% compared to the previous week, the month change is a 12.50% rise, over the last year EUROPEAN MEDICAL SOLUTION has showed a −14.29% decrease.
ALEMS reached its all-time high on Jun 13, 2024 with the price of 0.0230 EUR, and its all-time low was 0.0024 EUR and was reached on Sep 27, 2024. View more price dynamics on ALEMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALEMS stock is 11.76% volatile and has beta coefficient of 1.23. Track EUROPEAN MEDICAL SOLUTION stock price on the chart and check out the list of the most volatile stocks — is EUROPEAN MEDICAL SOLUTION there?
Today EUROPEAN MEDICAL SOLUTION has the market capitalization of 26.81 M, it has decreased by −3.13% over the last week.
Yes, you can track EUROPEAN MEDICAL SOLUTION financials in yearly and quarterly reports right on TradingView.
ALEMS net income for the last half-year is 362.00 K EUR, while the previous report showed −1.43 M EUR of net income which accounts for 125.24% change. Track more EUROPEAN MEDICAL SOLUTION financial stats to get the full picture.
No, ALEMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EUROPEAN MEDICAL SOLUTION EBITDA is 1.76 M EUR, and current EBITDA margin is 5.28%. See more stats in EUROPEAN MEDICAL SOLUTION financial statements.
Like other stocks, ALEMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUROPEAN MEDICAL SOLUTION stock right from TradingView charts — choose your broker and connect to your account.